St. Marianna University School of Medicine, Kawasaki, Japan.
Acad Emerg Med. 2012 Jul;19(7):782-92. doi: 10.1111/j.1553-2712.2012.01387.x.
This study aimed to investigate whether early epinephrine administration in out-of-hospital cardiopulmonary arrest (OHCA) patients was associated with improved outcomes and to address the selection bias inherent in observational studies (more severe cases are more likely to receive epinephrine).
This was a retrospective analysis of prospectively collected population-based data of adult bystander-witnessed OHCA patients from a nationwide Japanese registry between January 2007 and December 2008. To address selection bias, those who attained early return of spontaneous circulation (ROSC) without epinephrine administration were excluded, leaving 49,165 patients in the analysis. The outcomes were intact neurologic survival, defined as survival with cerebral performance category score 1 or 2, and any survival at 1 month or at discharge (whichever was earlier). The primary predictor was the time from the start of cardiopulmonary resuscitation (CPR) by emergency medical services (EMS) to first epinephrine administration, with early epinephrine defined as within 10 minutes.
Multivariate logistic regression analysis showed that cardiac origin OHCA patients who received early epinephrine (≤ 10 minutes) had significantly higher rates of intact neurologic survival (odds ratio [OR]=1.39, 95% confidence interval [CI]=1.08 to 1.78) and any survival (OR=1.73, 95% CI=1.46 to 2.04) than those who did not receive early epinephrine, after adjusting for potential confounders. Results for noncardiac OHCA patients were similar.
Early epinephrine administration may be associated with higher rates of intact neurologic survival and any survival in adult bystander-witnessed OHCA patients. This article provides a potential method to address the selection bias inherent in observational studies that examine the effects of drug administration in OHCA patients.
本研究旨在探讨院外心脏骤停(OHCA)患者早期肾上腺素给药是否与改善预后相关,并解决观察性研究中固有的选择偏倚(更严重的病例更有可能接受肾上腺素治疗)。
这是对 2007 年 1 月至 2008 年 12 月期间来自日本全国注册登记处的成年旁观者目击 OHCA 患者前瞻性收集的基于人群的数据集进行的回顾性分析。为了解决选择偏倚问题,排除了那些未接受肾上腺素治疗但早期恢复自主循环(ROSC)的患者,在分析中留下了 49165 名患者。主要结局为完整的神经功能存活,定义为存活且格拉斯哥预后评分 1 或 2 分,以及 1 个月或出院时任何存活(以较早者为准)。主要预测因素是急救医疗服务(EMS)开始心肺复苏(CPR)到首次肾上腺素给药的时间,早期肾上腺素定义为 10 分钟内。
多变量逻辑回归分析显示,接受早期肾上腺素(≤10 分钟)的心脏来源 OHCA 患者,其完整的神经功能存活(比值比 [OR]=1.39,95%置信区间 [CI]=1.08 至 1.78)和任何存活(OR=1.73,95% CI=1.46 至 2.04)的比率显著高于未接受早期肾上腺素治疗的患者,在调整了潜在混杂因素后。非心脏来源 OHCA 患者的结果相似。
早期肾上腺素给药可能与成年旁观者目击 OHCA 患者更高的完整神经功能存活和任何存活的比率相关。本文提供了一种潜在的方法,可以解决观察性研究中固有的选择偏倚问题,这些研究旨在检查 OHCA 患者药物治疗的效果。